Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Flunarizine dihydrochloride
Cat. No.:
0225LY-1449
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Flunarizine dihydrochloride is a selective calcium channel blocker with H1-blocking and calmodulin-binding properties used for vertigo, peripheral vascular disease, and migraine prevention.
Synonym:
Flunarizine 2HCl; KW-3149;R14950; 30484-77-6; Flunarizine 2HCl; Flunarizine HCl; Flunarizine (dihydrochloride); 1-(Bis(4-fluorophenyl)methyl)-4-cinnamylpiperazine dihydrochloride; Flunarizine (as hydrochloride); (E)-1-(Bis-(p-fluorophenyl)methyl)-4-cinnamylpiperazine dihydrochloride; 1-[bis(4-fluorophenyl)methyl]-4-[(E)-3-phenylprop-2-enyl]piperazine;dihydrochloride; 1-[Bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)piperazine dihydrochloride; Piperazine, 1-(bis(4-fluorophenyl)methyl)-4-(3-phenyl-2-propenyl)-, dihydrochloride, (E)-; Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propen-1-yl]-, hydrochloride (1:2)
CAS No.:
30484-77-6
Compound CID:
5282407
Formula:
C26H28Cl2F2N2
Formula Weight:
477.42
Specification
Targets&IC50:
Ca2+ channel: 68 nM(Ki)
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Flunarizine dihydrochloride can be used in neuroscience research to study the blockade of calcium and sodium channels in migraine and epilepsy models.
Library Information
Target:
Sodium channel; Dopamine receptor; Calcium channel
Receptor:
Calcium channel; Dopamine receptor; Sodium channel
Pathways:
Metabolism; Neuronal signaling; GPCR/G protein signaling; Membrane transporter/Ion channel
Plate Number:
AOCL-19
Plate Location:
f2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 104.73 mM
Ethanol Max Solubility:
2.4 mg/mL; 5.03 mM





